FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

LLY

Lilly (Eli)NYSE · Pharmaceuticals · Health Care
Previous close
1,137.82
Change
+1.71 / +0.15%
FinDog View
Bullish
52-Week Range
712.05 – 1,292.65
P/E (TTM)
39.9
Forward P/E
28.5
Based on consensus earnings for the next 12 months
Market Cap
$1.07T
1M
−3.83%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.5M / 2.1M
0.70× average

Price History

Closing price · USD1M6M1Y5Y
110011501200125013002026-082026-082026-092026-092026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 40.21M6M1Y5Y
3537.54042.5452026-032026-052026-062026-082026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-08-05$23.0B8.38 / 6.07+1.89%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-04-30$19.8B8.55 / 6.73+3.07%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-04—— / —−7.79%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-30—— / —+2.17%Pending
FY2025 Q2
Quarter ended 2025-06
2025-08-07—— / —−2.37%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-01—— / —+3.72%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 6 of its 5-year rangeCheap
5-year range 39.4 – 133.1 · Median 74.8
Last 4 quarters: $6.2B in buybacks + $5.8B in dividends, 1.12% of market cap combined
P/E (TTM)
39.9
P/B
31.5
P/S
13.4
Dividend Yield
0.75%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.5% on average on the first trading day after, rising 4 times
Most recent +1.89%
Volatility & Correlation
1-year beta 0.25 · Correlation with S&P 500 0.10Low beta
Annualized volatility 34% vs. 14% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $16.0MNet selling $16.0M
  • 08-17Jonsson PatrikEVP & President, LLY Int'lSell$7.6M6,500 shares · Avg price 1,175.10
  • 08-10Zakrowski Donald ASVP, Finance, & CAOSell$2.4M2,000 shares · Avg price 1,185.01
  • 08-07Hakim AnatEVP, GC & SecretarySell$6.0M5,000 shares · Avg price 1,190.00
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q222.97+47.7%85.8%—7.1010.697.94
FY2026 Q119.80+55.5%81.9%—7.405.338.26
FY2025 Q419.29+42.5%82.5%—6.643.227.39
FY2025 Q317.60+53.9%82.9%—5.588.846.21
FY2025 Q215.56+37.6%84.3%—5.663.096.29
FY2025 Q112.73+45.2%82.5%—2.761.673.06
FY2024 Q413.53+44.7%82.2%—4.412.474.88
FY2024 Q311.44+20.4%81.0%—0.973.711.07
FY2024 Q211.30+36.0%80.8%—2.971.473.28
FY2024 Q18.77+26.0%80.9%—2.241.172.48
FY2023 Q49.35+28.1%80.9%—2.19-0.312.42
FY2023 Q39.50+36.8%80.4%—-0.062.19-0.06

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%Bullish
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare
ABTAbbott Laboratories$177B33.2+7.8%56.2%−7.26%NeutralCompare